Unilever And Glaxo - A Classic Arbitrage Example

The Unilever bid for certain Glaxo assets produces a classic example of a standard arbitrage technique. Precisely because this is a standard technique seasoned market players can probably skip most of it. This is more of a guide to those learning about the markets than it is advice to those who already know their stuff.
Picture for Unilever And Glaxo - A Classic Arbitrage Example

Hot Stocks: Meme stocks fall; MSFT buys ATVI; SI drops on earnings; HMHC looking to sell; UL looking to buy

Stock traders returned after the three-day holiday weekend with selling on their minds. The major averages posted notable losses, led by a 2.6% drop in the Nasdaq. Amid the selling spree, meme stocks were particularly hard hit. As investors jettisoned speculative names, one-time high-fliers like AMC (NYSE:AMC), GameStop (NYSE:GME), Bed Bath & Beyond (NASDAQ:BBBY) and Inovio Pharmaceuticals (NASDAQ:INO) all posted notable losses.

GSK’s consumer promise will be hard to live up to

LONDON, Jan 19 (Reuters Breakingviews) - GlaxoSmithKline (GSK.L) is making a play for the premium aisle of consumer health. The maker of Lemsip drinks and Advil painkillers rejected Unilever’s (ULVR.L) 50 billion pound offer for its consumer unit. To keep investors on side with her alternative plan to spin off the division, Chief Executive Emma Walmsley has rolled out some punchy sales forecasts.
Motley Fool

This Defensive Consumer Stock Fell More Than 2 Meme Stock Darlings Today

Markets fell sharply on Monday. Meme stocks AMC and GameStop were among top decliners. Yet their drops paled in comparison to consumer-goods giant Unilever. Wall Street was in a foul mood on Tuesday, and major market benchmarks finished the day with substantial losses. The Dow Jones Industrial Average (DJINDICES:^DJI) was the best performer on the day despite finishing down more than 500 points, while the Nasdaq Composite (NASDAQINDEX:^IXIC) had much larger losses on a percentage basis that pushed that index into 10% correction territory. The S&P 500 (SNPINDEX:^GSPC) dropped nearly 2%.

Top Glaxo scientist defects to join Jeff Bezos’s bid to defy ageing

Dame Emma Walmsley's campaign to reignite growth at GlaxoSmithKline by focusing on cutting-edge drug research has suffered a heavy blow with the resignation of Hal Barron, the superstar scientist she headhunted and paid more than herself. Mr Barron has quit Glaxo to join Altos Labs, a biotech start-up lavishly funded...
Triple Pundit

22 New Plant-Based Foods Coming to Market in 2022

Sales of plant-based foods are booming, and the segment is poised to reach $37.9 billion in market value by 2027. As more consumers gravitate toward flexitarian diets — in other words, eating less meat and enjoying more meals without it — brands are coming to market with a rapidly expanding array of plant-based foods that tout a taste and texture that's just like the real thing. Here are a few standouts, coming soon to restaurants and retailers near you. (If you plant to sample some of them, please remember to do so safely: Wear a mask, keep your distance and be kind to frontline workers.)

Billionaire Jim Mellon Calls On Big Firms To ‘Prioritize’ Cell-Cultured Meat

British billionaire, investor, and author Jim Mellon believes we need to make investment in alternative protein sources a national priority. During an interview, he suggested establishing an industry association in the UK. He said this would encourage government ministers and big businesses to put their expertise, knowledge, and investment behind...

How Social Enterprises Can Help Corporations Meet Their ESG Goals

The private sector is undergoing a seismic transformation, driven in part by the climate crisis, Covid-19, and extreme financial inequality. These external factors have prompted the world’s corporate leaders to focus on their social responsibilities and make bold, ambitious commitments to environmental, social, and governance (ESG) goals. To deliver on these commitments, many will rely on corporate social responsibility (CSR) initiatives, but CSR alone isn’t enough to achieve meaningful progress.

Unilever fighting to buy GlaxoSmithKline, Pfizer joint venture

After three rejected bids, London-based Unilever said it is still interested in purchasing GSK Consumer Healthcare, which is a joint venture between GlaxoSmithKline and Pfizer and makes popular products such as Advil and ChapStick, The New York Times reported Jan. 18. Unilever said in a press release Jan. 16 that...

Unilever (LON:ULVR) PT Set at GBX 4,650 by Jefferies Financial Group

Several other research firms have also recently issued reports on ULVR. Berenberg Bank reaffirmed a “hold” rating and set a GBX 4,400 ($60.04) price objective on shares of Unilever in a research report on Friday, January 14th. Citigroup reaffirmed a “buy” rating and issued a GBX 4,500 ($61.40) price target on shares of Unilever in a report on Monday, January 10th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 4,600 ($62.76) price objective on shares of Unilever in a research note on Wednesday, December 15th. Barclays cut their price target on shares of Unilever from GBX 4,800 ($65.49) to GBX 4,600 ($62.76) and set an “overweight” rating on the stock in a research note on Friday, January 14th. Finally, The Goldman Sachs Group set a GBX 4,700 ($64.13) price objective on shares of Unilever in a research report on Wednesday, December 15th. Four research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. According to data from, Unilever has an average rating of “Hold” and a consensus target price of GBX 4,233.33 ($57.76).

Unilever shareholder's attack on sustainability messaging 'flawed,' experts say

This week’s attack on Unilever by British fund manager Terry Smith was “flawed," according to sustainability marketing experts, who predict "purpose" and "sustainability" will increasingly become “a stick to beat away poor performance." They also warned that greenwashing poses one of the biggest threats to consumer trust...